In this study, we found that SIN could significantly suppress the expression of MMP9 protein (Fig. 10H,I), which suggests that SIN could be used to treat patients with RA by inhibiting the overexpression of MMP9 protein. The gene discussed is MMP9; the disease is rheumatoid arthritis.